glp-1 weight-loss drugs Patients' Use for Weight Loss, Benefit Gains Professor Receives Grant to Study
Description
Glucagon-like peptide-1 (GLP-1) agonists have transformed weight loss treatments
However, it is still being studied and is not currently approved for routine medical use
would be interested in taking prescription weight-loss drugs, though interest drops if the drug is not covered by insurance or after hearing patients might gain weight back after stopping use
2011, 300: H1361-H1372
Weight loss in weight watchers online with and without an activity tracking device compared to control: a randomized trial
PBAC advice on equitable access to GLP-1 obesity treatments. Diabetes Australia
